facebook twitter linkedin instagram youtube spotify
×
<
>
loading_icra
bg-rating-rationales

Entity-Specific Rating Rationales

25 Feb 2025

Mankind Pharma Limited: Long-term rating reaffirmed; short-term rating reaffirmed/ assigned

Mankind Pharma Limited: Long-term rating reaffirmed; short-term rating reaffirmed/ assigned

30 Sep 2024

Mankind Pharma Limited: Ratings reaffirmed for existing non-convertible debentures; ratings assigned for bank loans, commercial papers and non-convertible debentures

Mankind Pharma Limited: Ratings reaffirmed for existing non-convertible debentures; ratings assigned for bank loans, commercial papers and non-convertible debentures

05 Aug 2024

Mankind Pharma Limited - Update on Material Event

Mankind Pharma Limited - Update on Material Event

09 Jul 2024

Mankind Pharma Limited: Rating assigned

Mankind Pharma Limited: Rating assigned

bg-rating-crediet-reports

Entity-Specific Credit Perspective Reports

26 Mar 2025

Mankind Pharma Limited

Mankind Pharma Limited (Non-SF)

29 Oct 2024

Mankind Pharma Limited

Mankind Pharma Limited (Non-SF)

02 Sep 2024

Mankind Pharma Limited

Mankind Pharma Limited (Non-SF)

Ratings

Description
Short Term
Medium Term
Long Term
Issuer
Long-term/short term fund-based limits [ICRA]A1+ -- [ICRA]AA+(Stable) --
Non-Convertible Debentures -- -- [ICRA]AA+(Stable) --
Commercial Papers [ICRA]A1+ -- -- --

Our Analysts

Analyst 1

Gaurav Kushwaha

Analyst 2

Deepak Jotwani

Sector Head

Shamsher Dewan
bg-rating-research

Most Trending Research Reports


View More
bg-rating-rationales

Rating Rationales

icon-download

View More
Upcoming Webinars
Presentations And Recordings

Coming Soon...

View More
08 Apr 2025 04:00 PM

ICRA Webinar on the Indian Banking Sector - Regulatory easing to support credit growth in FY2026; asset quality remains monitorable

--By Mr Karthik Srinivasan,Mr Anil Gupta,Mr Sachin Sachdeva
PPT
03 Apr 2025 04:00 PM

ICRA Webinar on Outlook FY2026

--By Mr. K Ravichandran,Ms. Aditi Nayar,Mr. Karthik Srinivasan
PPT
View More

Podcast

View More

Media Release



View More
banner-ask-expert
Ask Our Industry Analyst
Get in touch with our Business Representative
You can show error msg here
(*Denotes Compulsory field)

Submit